Diabetes, Heart and Cardiovascular Diseases News Chronicle. Diabetes, Cardiovascular and Heart Diseases. Article 274
Published on December 3, 2017 at 04:30 PM GMT


 



Permanent dysfunction of blood vessels with pregnancy preeclampsia condition in women

Pregnancy preeclampsia increases risks to type 2 diabetes, blood pressure, heart diseases and stroke.

Studies show preeclampsia condition affects around seven percent of the pregnant women in the United States. Earlier studies show preeclampsia increases the risk of high blood sugar glucose levels (type 2 diabetes T2D), high blood pressure, heart diseases and stroke. A study supported by the National Institutes of Health, Maryland, United States and done by Penn State researchers shows lifelong cardiovascular disease risks with pregnancy preeclampsia condition in women.



Researchers in their studies compared to blood vessels functioning among women who had preeclampsia and no preeclampsia during their pregnancies. Researchers have observed permanent dysfunction of blood vessels (change in the way blood vessels function) in those pregnant women who had pregnancy preeclampsia condition. Due to this permanent change in the functioning of blood vessels, those women face lifelong higher cardiovascular disease risks, even though they recovered from preeclampsia after giving birth. Researchers say their findings will help in developing better treatment options for the prevention of cardiovascular diseases.

Author of the study was Anna E. Stanhewicz, Department of Kinesiology, Pennsylvania State University. The study findings were published on September 12, 2017, in the Hypertension. Title of the article was "Increased Angiotensin II Sensitivity Contributes to Microvascular Dysfunction in Women Who Have Had Preeclampsia."



       
If you like this article, please share it with a friend! Article address is (copy and paste the code below):

Also, related to this story
1. Mothers with pregnancy preeclampsia may encounter heart diseases and stroke later in life
2. Preeclampsia or gestational hypertension was linked to increased future heart disease risk in women
3. Blood Vessel Function Benefits With Weight Lifting Exercises
4. Exercise protein cardiotrophin 1 (CT1) stimulates growth of blood vessels, helps growth of heart muscle & ventricle in a healthy way and improves ability of the heart to pump more blood
5. Hyperglycemia & New AP39 Drug To Prevent Blood Vessel Complications Due To Hydrogen Sulfide (H2S)
6. Benefits With Exercise For Obese Pregnant Women
7. Risks With Metabolic Conditions During Pregnancy
8. Benefits With Weight Loss During Pregnancy
9. Avoiding Miscarriage In Pregnant Women With Congenital Heart Disease
10. Increased risk of gestational diabetes and high blood sugar levels (hyperglycemia) with short sleep duration

 



Risks to cardiovascular diseases and bone fractures with the use of aromatase inhibitors among postmenopausal women

Heart attack failure, cardiovascular diseases and bone fractures with aromatase inhibitor drugs.

Postmenopausal women with breast cancer is being treated with aromatase inhibitors (AIs) drugs. But there are doubts whether aromatase inhibitors (AIs) increases risks to cardiovascular diseases.

A study done by researchers from Princess Margaret Cancer Center, Toronto, Canada and the University of Toronto, Canada shows increased risk of bone fractures and heart diseases such as heart attack, cardiovascular diseases, angina and heart failure with an extended or long-term usage of aromatase inhibitors (AIs) drugs in early breast cancer treatment.



The current study was conducted among 16,349 patients. The study results show an increased unfavorable effect on cardiovascular health, bone fractures and treatment discontinuation with a long-term aromatase inhibitors (AIs) drug treatment. Their study also shows increased risk with aromatase inhibitors (AIs) drugs compared to tamoxifen drug in the treatment of breast cancer in women patients. The following table shows the quantum of health diseases risks with aromatase inhibitors (AIs) drugs.

Health complication Relative risk % Absolute risk %
Cardiovascular disease 18% 4.8%
Bone fractures 45% 0.8%
Extended aromatase inhibitors (AIs) drugs treatment did not change the chances of either death without recurrence of breast cancer or second cancerous growth (malignancy).

But researchers could not find out whether the risk reduction is due better protective tamoxifen drug effect or adverse risk is due to adverse aromatase inhibitors (AIs) drugs.

Author of the study was Dr. Eitan Amir, MB, ChB, Ph.D, senior fellow, Medical Oncologist, Princess Margaret Hospital, Toronto, Canada. The study findings were published on August 4, 2017, in the Journal of the National Cancer Institute. Title of the article was "Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis."



       
Post a message on social media and mail to your friend. Article address is (copy and paste the code below):

Also, related to this story
1. Risk Of Heart Diseases In Postmenopausal Women
2. Risks To Postmenopausal Women
3. Enhanced risk of type 2 diabetes, cardiovascular disease (CVD) and overall mortality with an early menopause
4. Increased Heart Failure Risk With In Women With Early Menopause And Never Giving Birth
5. Aspirin may cut breast cancer risk for women with diabetes
6. Hot Flashes During Menopause Were Linked To Heart Diseases
7. Risks With Menopause In Women
8. Risks To Heart Attack And Diabetes Before Menopause
9. Cardiovascular Disease Risks In Endometrial Cancer Survivors
10. Risks With Early Or Late Menopause

 



Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.